Study of a new drug for advanced head and neck cancer and other solid tumors
Part of Cancer clinical trials.
This trial is testing an experimental medication called BL-M08D1 for people with head and neck cancer that has come back or spread, as well as other types of solid tumors. The goal is to see if the drug is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have head and neck cancer or another solid tumor that has returned or spread.
- Your cancer can be measured on scans.
- You are generally well enough to be up and about (ECOG score 0 or 1).
- You have recovered from side effects of previous cancer treatments.
- You agree to provide a tumor sample (either from a past biopsy or a new one).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug, BL-B16D1, for people with advanced head and neck cancer or other solid tumors that have not been helped by standard treatments. The goal is to see if the drug is safe and effective.
This study tests an experimental drug called BL-M08D1 for people with recurrent or metastatic gynecological cancers and other solid tumors. The drug is designed to target and kill cancer cells, and the study aims to see if it is safe and effective.
This study tests a new drug called BL-M08D1 for people with nasopharyngeal cancer or other solid tumors that have returned or spread. The trial is in early phases to see how safe the drug is and whether it can shrink tumors.
This trial is testing a new drug called BL-M08D for people with melanoma or other solid tumors that have spread. The drug aims to attack cancer cells, and researchers want to see if it is safe and effective.
This study tests a new drug called BL-M08D for people with advanced solid tumors, especially those in the digestive tract (like stomach, colon, or pancreas). The goal is to see if it is safe and effective, and it might help shrink tumors or slow their growth.
This trial tests an investigational drug, SI-B036, for people with advanced head and neck tumors or other solid tumors that have spread. The goal is to see if the drug can shrink tumors and slow the disease.
Hear when a new Head and Neck Squamous Cell Carcinomas trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.